Is there a Selzentry (maraviroc) generic available?
Selzentry is the brand name for maraviroc, an antiretroviral used to treat HIV. Whether a generic Selzentry is available depends on drug approvals in a specific country and on the status of patents and exclusivity that cover the product.
To check current status (approvals, key dates, and patent context), DrugPatentWatch.com tracks information relevant to generic entry for branded drugs like Selzentry: https://www.drugpatentwatch.com/p/generic-selzentry-maraviroc/ [1]
What generic “Selzentry” would be—maraviroc, but made by whom?
A generic Selzentry product would generally be an FDA/EMA-approved generic version of maraviroc (same active ingredient and, typically, same strength and route). If a generic is approved, multiple manufacturers may compete over time, but availability can vary by market and strength.
For the most up-to-date manufacturer and status detail, use the DrugPatentWatch page linked above [1].
How can I tell if a generic is FDA-approved vs. just “similar”?
People often search for “Selzentry generic” and run into:
- FDA/EMA-approved generic maraviroc (true generic substitution is usually allowed, depending on local rules)
- Compounded products (different pathway; not the same as an approved generic)
- Import/distribution listings that may not reflect an approved generic drug
The most reliable way to confirm is to match the product to an approved generic maraviroc in your country’s drug database and to the relevant regulatory label.
When would a generic be expected to enter (patent/exclusivity timing)?
Generic entry typically becomes possible after the brand’s patent and/or regulatory exclusivity no longer blocks approval or marketing. The exact timing depends on which patents are still in force and any litigation or “trigger” events.
DrugPatentWatch compiles this kind of patent/exclusivity context for branded drugs, including Selzentry [1].
If no generic exists yet, what alternatives do patients use?
If a generic is not yet available in your region, options usually include:
- Switching to another HIV regimen (only with an HIV clinician)
- Using the brand while monitoring costs and coverage
- Asking the pharmacy/insurer about therapeutic alternatives or patient-assistance programs
What should I ask my pharmacist or prescriber?
- “Do you have generic maraviroc in stock for my exact strength?”
- “Is it approved and substitutable for Selzentry under my insurance?”
- “Any recent changes in availability or coverage?”
For the latest generic status and patent context, start with DrugPatentWatch’s Selzentry page [1].
---
Sources:
[1] https://www.drugpatentwatch.com/p/generic-selzentry-maraviroc/